- $1.44bn
- $2.89bn
- $2.76bn
Annual income statement for CBIZ, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,105 | 1,412 | 1,591 | 1,813 | 2,758 |
| Cost of Revenue | |||||
| Gross Profit | 159 | 233 | 225 | 187 | 355 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 1,026 | 1,243 | 1,426 | 1,735 | 2,515 |
| Operating Profit | 78.7 | 169 | 165 | 78.6 | 243 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 93 | 141 | 166 | 57.8 | 161 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 70.9 | 105 | 121 | 41 | 115 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 70.9 | 105 | 121 | 41 | 115 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 70.9 | 105 | 121 | 41 | 115 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.67 | 2.16 | 2.44 | 1.37 | 2.45 |